Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05635851 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI

Study acronym: NO AD
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Feb 2026 to Feb 2028
    • Start date: Sep 2025 to Dec 2026
    v5
  2. Primary and study completion dates: Feb 2025 to Feb 2026
    • Start date: Sep 2024 to Sep 2025
    v4
  3. Primary and study completion dates: Feb 2024 to Feb 2025
    • Start date: Sep 2023 to Sep 2024
    v3
  4. Start date: Feb 2023 to Sep 2023v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project aims to evaluate the safety and efficacy of using a short-acting drug to reduce the maximal blood pressure during dangerous blood pressure spikes that happen during bowel care in individuals with spinal cord injury. the investigators will monitor the physiological effects of this drug during at-home bowel care to best understand the drug's effects in typical use.
Trial Details
NCT Number NCT05635851
Lead Sponsor Simon Fraser University
Collaborators: University of British Columbia
Conditions
(from sponsor)		 Spinal Cord Injuries, Autonomic Dysreflexia
Related terms Autonomic Dysreflexia, Spinal Cord Injuries
Enrollment 26 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov